Search Within

Sean McCarthy Devlin

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (5)
Groups
  1. Adult Leukemia (11)
  2. Biostatistics Service (11)
  3. Center for Hematologic Malignancies (11)
  4. Department of Medicine (11)
  5. Epidemiology and Biostatistics (11)
  6. GSK Faculty (11)

More Groups

People
  1. Jae Park (8)
  2. Renier Brentjens (8)
  3. Michel Sadelain (7)
  4. Isabelle Riviere (6)
  5. Maria Palomba (6)
  6. Elizabeth Halton (4)

More People

Years
  1. 2023 (3)
  2. 2022 (1)
  3. 2021 (1)
  4. 2019 (2)
  5. 2018 (1)
  6. 2015 (1)

More Years

Publications
  1. Blood (4)
  2. Nature Medicine (2)
  3. Clinical Lymphoma, Myeloma and Leukemia (1)
  4. JCI Insight (1)
  5. Molecular Therapy (1)
  6. New England Journal of Medicine (1)

More Publications

Publishers
  1. American Society of Hematology (4)
  2. Nature Publishing Group (3)
  3. Amer Assoc Advancement Science (1)
  4. Amer Soc Clinical Investigation Inc (1)
  5. Elsevier Inc. (1)
  6. Massachusetts Medical Society (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2
    Meeting Abstract

    Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Devlin, S. M.; Valtis, Y. K.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E.; Liotta, K.; Yu, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: Phase 2 trial interim results
    Journal Article

    Park, J. H.; Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G.; Dahi, P.; Lin, R. J.; Scordo, M.; Perales, M. A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
    Journal Article

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K. V.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • The intestinal microbiota correlates with response and toxicity after CAR T cell therapy in patients with B-cell malignancies
    Meeting Abstract

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage
    Journal Article

    Takashima, S.; Martin, M. L.; Jansen, S. A.; Fu, Y.; Bos, J.; Chandra, D.; O'Connor, M. H.; Mertelsmann, A. M.; Vinci, P.; Kuttiyara, J.; more...
    Science Immunology (2019)

    Fulltext@MSK | Save
  • Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL
    Journal Article

    Geyer, M. B.; Riviere, I.; Senechal, B.; Wang, X.; Wang, Y.; Purdon, T. J.; Hsu, M.; Devlin, S. M.; Palomba, M. L.; Halton, E.; more...
    JCI Insight (2019)

    Fulltext@MSK | Save
  • Autologous CD19-Targeted CAR T cells in patients with residual CLL following initial purine analog-based therapy
    Journal Article

    Geyer, M. B.; Rivière, I.; Sénéchal, B.; Wang, X.; Wang, Y.; Purdon, T. J.; Hsu, M.; Devlin, S. M.; Halton, E.; Lamanna, N.; more...
    Molecular Therapy (2018)

    Fulltext@MSK | Save
  • Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia
    Journal Article

    Tiacci, E.; Park, J. H.; De Carolis, L.; Chung, S. S.; Broccoli, A.; Scott, S.; Zaja, F.; Devlin, S.; Pulsoni, A.; Chung, Y. R.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • The Warburg effect confers adverse outcome in chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S. M.; Knapp, K.; Bauli, F.; Patel, M.; Lamanna, N.; Frattini, M. G.; Brentjens, R.; Maslak, P.; Jurcic, J. G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save